Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

People with male pattern baldness are more likely to have metabolic syndrome.

Some supplements and hormones can increase hair loss by raising DHT levels.

Skin conditions can signal diabetes and insulin resistance.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Coping skills in PCOS patients don't significantly affect mental health, quality of life, or body weight.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Cadmium chloride pollution can cause skin disorders, speed up aging, and prevent hair growth.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

The study created a new method to test drugs that affect hormone processing in skin.

Restoring NAD⁺ may help with aging and chronic diseases, but more research is needed.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Hair growth genes work better with more glucose due to changes in gene-regulating markers.